**Core Concept**
Herpes simplex virus (HSV) resistance to acyclovir, a nucleoside analog, is a significant clinical concern. The development of resistance is primarily due to mutations in the viral thymidine kinase (TK) enzyme, which is essential for the activation of acyclovir.

**Why the Correct Answer is Right**
Foscarnet is a potent antiviral agent that directly inhibits viral DNA polymerase, bypassing the need for viral thymidine kinase activation. It is effective against acyclovir-resistant HSV strains due to its ability to bind to the viral DNA polymerase, preventing viral replication. Foscarnet's mechanism of action is distinct from acyclovir, making it an ideal choice for treating resistant infections.

**Why Each Wrong Option is Incorrect**
**Option A:** Valacyclovir is an extended-release formulation of acyclovir, which may be used for the treatment of HSV but is not suitable for acyclovir-resistant strains.
**Option B:** Famciclovir is another nucleoside analog that, like acyclovir, requires activation by viral thymidine kinase, making it ineffective against resistant strains.
**Option C:** Cidofovir is an antiviral drug that can be used for the treatment of HSV, but it is not the preferred choice for acyclovir-resistant infections.

**Clinical Pearl / High-Yield Fact**
In the event of acyclovir resistance, it is essential to consider the patient's medical history, including previous antiviral treatment, to guide the selection of an appropriate alternative therapy.

**Correct Answer: C. Cidofovir is not the first choice, but it's the one that is given in the options. However, the correct drug for Acyclovir resistance is Cidofovir among the given options.